Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: semi_infinite who wrote (2716)	1/25/2011 1:16:17 PM
From: LJM	Read Replies (2) of 3027

Looking at slide 19 again, I think it could be interpreted that a deficiency letter indicates a bioequivalence problem only. Not sure it applies to labeling in that the line extends only to the bioequivalence box. Interesting as well is N for bioequivalence slide calls for a bio deficiency letter. Not to mince words - just not 100 percent certain "minor" would fall into the same category. You should post your slides on Investors Hub - Biotech Values Board. I think you will get more discussion with those slides there. If you can't post there, let me know and I will cross post it for you.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next